Condition
Coma; Prolonged
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation1
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07074678Not ApplicableEnrolling By Invitation
Prognostication of Recovery in Early Disorders of Consciousness Study
NCT04921683Not ApplicableCompleted
The Use of LIFUP in Chronic Disorders of Consciousness
NCT03443037UnknownPrimary
Benefits of Amantadine in Patients With Coma State
Showing all 3 trials